2020 ASCO Virtual Direct™ Highlights

 

2020 ASCO Virtual Direct™ Highlights
L

2020 ASCO Highlights on PARPi in Recurrent Ovarian Cancer: Can a Non-Platinum Therapy Improve Clinical Outcome in Platinum Sensitive Disease?

By 2020 ASCO Virtual Direct™ Highlights FEATURING Lainie Martin
By 2020 ASCO Virtual Direct™ Highlights FEATURING Lainie Martin
67 views
September 30, 2020
0 Comments
Login to view comments. Click here to Login

Featured Video

20:59
Exelixis

Primary Analysis and Follow-up Data of a Combination Therapy in 1L a…

Feat. S. Ratnam

Featured Video

15:14
Icahn School of Medicine at Mount Sinai

Safety Profile of Ruxolitinib in Patients With MF

Feat. D. Tremblay
GYN
10:52
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update in on Recurrent Ovarian Cancer: What Is the Impact …

Feat. L. Martin
07:24
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on Recurrent Ovarian Cancer: Does Maintenance PARPi…

Feat. L. Martin
08:54
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Highlights on PARPi in Recurrent Ovarian Cancer: Can a Non…

Feat. L. Martin
07:08
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on Cervical Cancer: Is SLN Biopsy Alone Oncological…

Feat. L. Martin